Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Erythropoiesis
Leading National Patient Group Urges Government Officials to Preserve Access to Erythropoiesis Stimulating Agents for Cancer Patients
July 5th, 2007
The National Patient Advocate Foundation (NPAF) and its Scientific Advisory Board, representing millions of cancer and other chronically ill patients, have joined the chorus of leading physicians and researchers in the field of hematology and oncology in urging the Centers for Medicare and Medicaid Services (CMS) to maintain full patient access to Erythropoiesis Stimulating Agents (ESAs). "NPAF recognizes that there are real concerns about how ESA drugs are prescribed and how they are priced and marketed, and so we fully support the usage and pricing reviews that have been initiated in the Congress and elsewhere," said NPAF CEO Nancy Davenport-Ennis. "ESAs should only be...
Source: Blood Weekly (2007-07-05)
|
